{
    "success": true,
    "data": {
        "id": 1755628,
        "msgid": "indonesias-bpom-highlights-vaccine-regulation-at-wha-1779542494",
        "date": "2026-05-21 19:19:17",
        "title": "Indonesia's BPOM highlights vaccine regulation at WHA",
        "author": "",
        "source": "ANTARA_EN",
        "tags": "",
        "topic": "Regulation",
        "summary": "At the 79th World Health Assembly in Geneva (May 18-23, 2026), BPOM head Taruna Ikrar underscored that a strong regulatory system is vital to trust and accelerate vaccine development and production, especially for Global South countries. He highlighted ongoing collaboration and innovation to bolster health resilience and noted Indonesia's designation as a WHO-Listed Authority, a reflection of its regulatory capacity to ensure safety, efficacy and quality of health products. The Indonesian side event with the Developing Countries Vaccine Manufacturers Network, 'Advancing Local Production for Equitable Access, Resilient Health Systems, and Global Health Security,' aimed to strengthen local and regional vaccine production and access.",
        "content": "<p>\u201cA strong regulatory system is a strategic element in strengthening\ntrust and accelerating vaccine development and production, particularly\namong Global South countries,\u201d BPOM head Taruna Ikrar said in Jakarta on\nThursday.<\/p>\n<p>Speaking at a panel session titled \u201cBuilding Resilient Vaccine\nEcosystems,\u201d he said collaboration and innovation must continue to be\nstrengthened to support more resilient health systems in the future.<\/p>\n<p>According to him, stronger collaboration and innovation would help\nGlobal South countries improve public health resilience and quality of\nlife.<\/p>\n<p>\u201cIn this evolving landscape, collaboration is no longer an option but\na necessity,\u201d he said.<\/p>\n<p>The 79th WHA, held from May 18-23, 2026, in Geneva, Switzerland,\nfocused on strengthening global health systems, including expanding\naccess to health products, enhancing local manufacturing capacity, and\nimproving regulatory systems.<\/p>\n<p>WHO Director-General Tedros Adhanom Ghebreyesus announced on May 19\nthat Australia, Canada, Indonesia, Japan, and the United Kingdom had\nbeen designated as WHO-Listed Authorities (WLA).<\/p>\n<p>Tedros said the designation was aimed at accelerating\nprequalification and procurement processes.<\/p>\n<p>According to Ikrar, the designation reflects international\nrecognition of Indonesia\u2019s regulatory capacity in ensuring the safety,\nefficacy, and quality of health products in line with global\nstandards.<\/p>\n<p>He said Indonesia, together with the Developing Countries Vaccine\nManufacturers Network and global partners, also organized a side event\nduring the WHA titled \u201cAdvancing Local Production for Equitable Access,\nResilient Health Systems, and Global Health Security.\u201d<\/p>\n<p>He said the event served as a strategic forum for global health\nleaders, regulators, international organizations, vaccine manufacturers,\nand development partners to strengthen local and regional production\ncapacity.<\/p>\n<p>Related news: Indonesia\u2019s BPOM approves wider measles vaccine use\namid outbreaks<\/p>\n<p>Related news: Indonesia becomes first developing country with WHO WLA\nstatus<\/p>\n<p>Translator: Mecca Yumna Ning Prisie<\/p>",
        "url": "https:\/\/jawawa.id\/newsitem\/indonesias-bpom-highlights-vaccine-regulation-at-wha-1779542494",
        "image": ""
    },
    "sponsor": "Okusi Associates",
    "sponsor_url": "https:\/\/okusiassociates.com"
}